org placeholder image

Denzil Bernard

Director Cadd at Atomwise

  • LinkedIn

Email Email: d****@atomwise.com

phone noPhone Number: (***)-***-****

Computational chemist with expertise in pharmaceutical sciences; drug design, discovery and optimization; epigenetics and oncology; multidisciplinary, independent and collaborative research.

Read More

map
ATOMWISE

ATOMWISE

  • Employees count Employees 51-200
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Atomwise Org Chart and Mapping

J Medina

Admin Manager and Ea to the CEO

Employees

Ann Osullivan

Office Manager & Senior Administrative Assistant

Sam Eckert

Director, Engineering

Kyle Giesler

Sr. Scientist, Medicinal Chemistry

Cheng Hu

Associate Director, Medicinal Chemistry

Alex Lozovsky

Sr. IT MGR / Head of IT

Lien Ngo

Director, Program Management R&D

Hemanth Akkiraju

Associate Principal Scientist

David Graff

Scientist II, ML Research

Frequently Asked Questions Regarding Denzil Bernard

Answer: Denzil Bernard works for Atomwise as Director Cadd

Answer: Denzil Bernard’s role in Atomwise is Director Cadd

Answer: Denzil Bernard's email address is d***@gmail.com

Answer: Denzil Bernard's business email address is d****@atomwise.com

Answer: Denzil Bernard’s direct phone number is (***)-***-****

Answer: Denzil Bernard works in the industry of: Biotechnology

Answer: Denzil Bernard is the current Director Cadd at Atomwise.... Read More

Answer: Denzil Bernard works Atomwise located at 717 Market St, San Francisco, California, 94103, United States

Answer: Atomwise's Director Cadd is Denzil Bernard

Answer: Denzil Bernard contact details:

  • Phone number  :  (***)-***-****
  • Email  :  d****@atomwise.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access